These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10354384)

  • 1. The swirling phenomenon in stored platelets is influenced by their endogenous serotonin.
    Hervig T; Bakken AM; Farstad M
    Transfus Med; 1999 Jun; 9(2):139-45. PubMed ID: 10354384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous glutathione and platelet function in platelet concentrates stored in plasma or platelet additive solution.
    Hervig T; Mansoor MA; Farstad M
    Transfus Med; 2001 Apr; 11(2):97-104. PubMed ID: 11299026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.
    Bertolini F; Murphy S
    Transfusion; 1996 Feb; 36(2):128-32. PubMed ID: 8614962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion.
    Mathai J; Resmi KR; Sulochana PV; Sathyabhama S; Baby Saritha G; Krishnan LK
    Platelets; 2006 Sep; 17(6):393-6. PubMed ID: 16973500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis.
    Feys HB; Devloo R; Sabot B; De Pourcq K; Coene J; Compernolle V
    Vox Sang; 2017 Nov; 112(8):751-758. PubMed ID: 28960339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method.
    Van der Planken MG; Vertessen F; Mortelmans E; Van Bockstaele D; Muylle L; Mertens G; Berneman ZN
    Ann Hematol; 1999 Jan; 78(1):1-7. PubMed ID: 10037261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of filtration on subsequently stored platelet concentrates.
    Joustra-Dijkhuis AM; Boomgaard MN; Pietersz RN; Steneker I; de Korte D; Loos JA; Reesink HW
    Vox Sang; 1994; 67(1):22-7. PubMed ID: 7975447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of storage conditions of platelet concentrates prepared from pooled buffy coats.
    de Wildt-Eggen J; Bins M; van Prooijen HC
    Vox Sang; 1996; 70(1):11-5. PubMed ID: 8928484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'cherry buffy-coat syndrome', a cause of decreased platelet yield in platelet concentrates obtained from buffy-coats.
    Rebulla P; Smacchia C; Greppi N; Porretti L; Lopa R; Cernuschi M; Sirchia G
    Vox Sang; 2001 Jan; 80(1):57-60. PubMed ID: 11339070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates.
    Wagner SJ; Robinette D
    Transfusion; 1996; 36(11-12):989-93. PubMed ID: 8937410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH, PCO2 and PO2 in "high-volume" platelet concentrates prepared by discontinuous-flow centrifugation and stored in polyvinylchloride and plyethylene containers.
    Rosenstein R; Lawe JE; North JG
    Am J Clin Pathol; 1980 Mar; 73(3):397-9. PubMed ID: 7361720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time.
    Glas M; Bauer JV; Eichler H; Volk T
    Scand J Clin Lab Invest; 2016 Dec; 76(8):664-670. PubMed ID: 27701904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
    Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC
    Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 24 h resting of old PCs at 22-24°С in permeable bags on in vitro platelet parameters.
    Hossien TN; Farhad R; Gharib K
    Transfus Apher Sci; 2014 Feb; 50(1):106-10. PubMed ID: 24268768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of leukocyte-poor platelet concentrates from buffy coats. II. Lack of effect on storage of different plastics.
    Pietersz RN; Reesink HW; Dekker WJ
    Vox Sang; 1987; 53(4):208-13. PubMed ID: 3125685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.